Emily H. Cheng

30.4k total citations · 9 hit papers
94 papers, 16.4k citations indexed

About

Emily H. Cheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emily H. Cheng has authored 94 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 25 papers in Cancer Research and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emily H. Cheng's work include Cell death mechanisms and regulation (32 papers), Renal cell carcinoma treatment (16 papers) and Cancer Genomics and Diagnostics (15 papers). Emily H. Cheng is often cited by papers focused on Cell death mechanisms and regulation (32 papers), Renal cell carcinoma treatment (16 papers) and Cancer Genomics and Diagnostics (15 papers). Emily H. Cheng collaborates with scholars based in United States, Japan and Canada. Emily H. Cheng's co-authors include Stanley J. Korsmeyer, James J. Hsieh, Tullia Lindsten, Michael C. Wei, Craig B. Thompson, J. Marie Hardwick, Andrea J. Ross, Grant R. MacGregor, Wei‐Xing Zong and Kevin A. Roth and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Emily H. Cheng

94 papers receiving 16.2k citations

Hit Papers

Proapoptotic BAX and BAK:... 1997 2026 2006 2016 2001 2001 2003 1997 2006 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
    2001 3.3k citations Michael C. Wei, Wei‐Xing Zong et al. Science profile →
  2. BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis
    2001 1.4k citations Emily H. Cheng, Michael C. Wei et al. Molecular Cell profile →
  3. BAX and BAK Regulation of Endoplasmic Reticulum Ca 2+ : A Control Point for Apoptosis
    2003 1.2k citations Joseph T. Opferman, Emily H. Cheng et al. Science profile →
  4. Conversion of Bcl-2 to a Bax-like Death Effector by Caspases
    1997 943 citations Emily H. Cheng et al. Science profile →
  5. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
    2006 689 citations Hyungjin Kim, Ho-Chou Tu et al. profile →
  6. VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis
    2003 664 citations Emily H. Cheng, Stanley J. Korsmeyer et al. Science profile →
  7. BAX activation is initiated at a novel interaction site
    2008 542 citations Evripidis Gavathiotis, Motoshi Suzuki et al. Nature profile →
  8. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
    2016 531 citations A. Ari Hakimi, Chung‐Han Lee et al. profile →
  9. Apoptosis in Cancer Biology and Therapy
    2025 43 citations Allison Moyer, Kosuke Tanaka et al. Annual Review of Pathology Mechanisms of Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily H. Cheng United States 48 12.6k 2.6k 2.5k 2.3k 2.1k 94 16.4k
Brett P. Monia United States 77 13.9k 1.1× 3.3k 1.3× 3.4k 1.3× 3.0k 1.3× 1.7k 0.8× 274 21.8k
Spencer B. Gibson Canada 53 7.8k 0.6× 1.8k 0.7× 2.2k 0.9× 3.0k 1.3× 2.1k 1.0× 163 13.0k
Maria Castedo France 51 11.9k 0.9× 4.9k 1.9× 2.1k 0.8× 2.1k 0.9× 3.8k 1.8× 108 19.0k
María T. Díaz‐Meco United States 72 11.1k 0.9× 2.7k 1.0× 3.3k 1.3× 4.1k 1.8× 2.5k 1.2× 155 16.2k
Wei‐Xing Zong United States 43 8.4k 0.7× 2.1k 0.8× 2.2k 0.9× 2.1k 0.9× 2.0k 1.0× 79 12.0k
Juan Iovanna France 69 8.7k 0.7× 5.6k 2.1× 3.0k 1.2× 2.1k 0.9× 2.2k 1.0× 403 16.4k
Jorge Moscat United States 76 12.8k 1.0× 2.9k 1.1× 3.4k 1.4× 4.2k 1.8× 2.6k 1.2× 182 18.3k
Stephen W. G. Tait United Kingdom 49 10.0k 0.8× 1.9k 0.7× 1.8k 0.7× 3.4k 1.4× 3.5k 1.6× 87 15.5k
Ji Luo United States 43 12.1k 1.0× 4.2k 1.6× 2.7k 1.1× 1.3k 0.6× 1.5k 0.7× 99 16.0k
Steven Grant United States 79 16.7k 1.3× 6.3k 2.4× 2.3k 0.9× 2.1k 0.9× 2.2k 1.0× 451 23.2k

Countries citing papers authored by Emily H. Cheng

Since Specialization
Citations

This map shows the geographic impact of Emily H. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily H. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily H. Cheng more than expected).

Fields of papers citing papers by Emily H. Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily H. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily H. Cheng. The network helps show where Emily H. Cheng may publish in the future.

Co-authorship network of co-authors of Emily H. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Emily H. Cheng. A scholar is included among the top collaborators of Emily H. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily H. Cheng. Emily H. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moyer, Allison, Kosuke Tanaka, & Emily H. Cheng. (2025). Apoptosis in Cancer Biology and Therapy. Annual Review of Pathology Mechanisms of Disease. 20(1). 303–328. 43 indexed citations breakdown →
2.
Miyata, Non, et al.. (2017). The VDAC2–BAK axis regulates peroxisomal membrane permeability. The Journal of Cell Biology. 216(3). 709–722. 55 indexed citations
3.
Xu, Jianing, Can G. Pham, Steven K. Albanese, et al.. (2016). Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. Journal of Clinical Investigation. 126(9). 3526–3540. 77 indexed citations
4.
Garner, Thomas P., Denis E. Reyna, Amit Priyadarshi, et al.. (2016). An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway. Molecular Cell. 63(3). 485–497. 77 indexed citations
5.
Voss, Martin H., A. Ari Hakimi, Can G. Pham, et al.. (2014). Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy. Clinical Cancer Research. 20(7). 1955–1964. 156 indexed citations
6.
Cheng, Emily H., Timothy G. Whitsett, Nhan L. Tran, & Jeffrey A. Winkles. (2014). The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion. Molecular Cancer Research. 13(3). 575–583. 23 indexed citations
7.
Dong, Yiyu, et al.. (2014). Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis. Cell Research. 24(11). 1354–1366. 25 indexed citations
8.
Bean, Gregory R., Yogesh Tengarai Ganesan, Yiyu Dong, et al.. (2013). PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis. Science Signaling. 6(268). ra20–ra20. 97 indexed citations
9.
Hakimi, A. Ari, Irina Ostrovnaya, Boris Reva, et al.. (2013). Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network. Clinical Cancer Research. 19(12). 3259–3267. 267 indexed citations
10.
Takeda, Shugaku, Han Liu, Satoru Sasagawa, et al.. (2013). HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. Journal of Clinical Investigation. 123(7). 3154–3165. 51 indexed citations
11.
Oyama, Toshinao, Satoru Sasagawa, Shugaku Takeda, et al.. (2013). Cleavage of TFIIA by Taspase1 Activates TRF2-Specified Mammalian Male Germ Cell Programs. Developmental Cell. 27(2). 188–200. 29 indexed citations
12.
Whitsett, Timothy G., Emily H. Cheng, Landon J. Inge, et al.. (2012). Elevated Expression of Fn14 in Non-Small Cell Lung Cancer Correlates with Activated EGFR and Promotes Tumor Cell Migration and Invasion. American Journal Of Pathology. 181(1). 111–120. 45 indexed citations
13.
Chen, David Y., Brian A. Van Tine, Adam C. Searleman, et al.. (2011). A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth. Cancer Research. 72(3). 736–746. 35 indexed citations
14.
Chen, David Y., Han Liu, Shugaku Takeda, et al.. (2010). Taspase1 Functions as a Non-Oncogene Addiction Protease that Coordinates Cancer Cell Proliferation and Apoptosis. Cancer Research. 70(13). 5358–5367. 29 indexed citations
15.
Ren, Decheng, Ho-Chou Tu, Hyungjin Kim, et al.. (2010). BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program. Science. 330(6009). 1390–1393. 378 indexed citations
16.
Kim, Hyungjin, Ho-Chou Tu, Decheng Ren, et al.. (2009). Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis. Molecular Cell. 36(3). 487–499. 477 indexed citations
17.
Gavathiotis, Evripidis, Motoshi Suzuki, Marguerite L. Davis, et al.. (2008). BAX activation is initiated at a novel interaction site. Nature. 455(7216). 1076–1081. 542 indexed citations breakdown →
18.
Rotolo, Jimmy A., Jerzy Maj, Decheng Ren, et al.. (2008). Bax and Bak Do Not Exhibit Functional Redundancy in Mediating Radiation-Induced Endothelial Apoptosis in the Intestinal Mucosa. International Journal of Radiation Oncology*Biology*Physics. 70(3). 804–815. 55 indexed citations
19.
Ruiz‐Vela, Antonio, Joseph T. Opferman, Emily H. Cheng, & Stanley J. Korsmeyer. (2005). Proapoptotic BAX and BAK control multiple initiator caspases. EMBO Reports. 6(4). 379–385. 99 indexed citations
20.
Wei, Michael C., Wei‐Xing Zong, Emily H. Cheng, et al.. (2001). Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death. Science. 292(5517). 727–730. 3282 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brett P. Monia Breakdown of academic impact, for papers by Spencer B. Gibson Breakdown of academic impact, for papers by Maria Castedo Breakdown of academic impact, for papers by María T. Díaz‐Meco Breakdown of academic impact, for papers by Wei‐Xing Zong Breakdown of academic impact, for papers by Juan Iovanna Breakdown of academic impact, for papers by Jorge Moscat Breakdown of academic impact, for papers by Stephen W. G. Tait Breakdown of academic impact, for papers by Ji Luo Breakdown of academic impact, for papers by Steven Grant
Rankless by CCL
2026